Report workspace tools

NCT02682030COMPLETEDanonymous

Utilization of Pulmonary Clearance Devices in Amyotrophic Lateral Sclerosis

Sponsor

Source record

Cedars-Sinai Medical Center

Phase

Source record

NA

Modality

AI-normalized

medical device

Target

AI-normalized

High Frequency Chest Compression Device (HFCC), Cough Assist

Indication / condition

AI-normalized

Amyotrophic Lateral Sclerosis

Intervention

Source record

High Frequency Chest Compression Device (HFCC), Cough Assist

Source & freshness

Source record

NCT ID

NCT02682030

Original source

ClinicalTrials.gov

Source last updated

Aug 25, 2020

Ingested at

Jun 09, 2026

Internal sync

Jun 09, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT02682030

Title

Utilization of Pulmonary Clearance Devices in Amyotrophic Lateral Sclerosis

Sponsor

Cedars-Sinai Medical Center

Status

COMPLETED

Phase

NA

Condition raw

Amyotrophic Lateral Sclerosis

Condition normalized

Amyotrophic Lateral Sclerosis

Modality raw

medical device

Modality normalized

medical device

Target raw

High Frequency Chest Compression Device (HFCC), Cough Assist

Target normalized

High Frequency Chest Compression Device (HFCC), Cough Assist

Interventions

High Frequency Chest Compression Device (HFCC), Cough Assist

Public preview

Source record

The investigator is examining the use of one airway clearance medical device compared to the use of two airway clearance medical devices together in patients with amyotrophic lateral sclerosis (ALS). More specifically, the investigator wants to know how effective the use of either a mechanical High Frequency Chest Compression (HFCC) device is on its own or the use of both a mechanical High Frequency Chest Compression (HFCC) device and Cough Assist together to maintain a healthy airway and clear secretions.

The first device is a passive form of mechanical High Frequency Chest Compression (HFCC), which was designed to help clear the airway of mucus and other secretions through mechanical knocking of the chest area. The second device, called a Cough Assist, aids patients to clear mucus and secretions that they would otherwise be unable to clear with coughing. This study will enroll up to 20 people in total at CSMC.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account

Create a free account first, then unlock a single report, buy credits or subscribe.